Literature DB >> 9079628

HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation.

M Seeger1, K Ferrell, R Frank, W Dubiel.   

Abstract

The proteasomal system consists of a proteolytic core, the 20 S proteasome, which associates in an ATP-dependent reaction with the 19 S regulatory complex to form the functional 26 S proteasome. In the absence of ATP, the 20 S proteasome forms a complex with the gamma-interferon-inducible 11 S regulator. Both the 20 S proteasome and the 11 S regulator have been implied in the generation of antigenic peptides. The human immunodeficiency virus (HIV)-1 Tat protein causes a number of different effects during acquired immunodeficiency syndrome (AIDS). Here we show that HIV-1 Tat protein strongly inhibits the peptidase activity of the 20 S proteasome and that it interferes with formation of the 20 S proteasome-11 S regulator complex. In addition, it slightly increases the activity of purified 26 S proteasome. These results may explain the mechanism by which HIV-1-infected cells escape cytotoxic T lymphocyte response and at least in part immunodeficiency in AIDS patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9079628     DOI: 10.1074/jbc.272.13.8145

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Relationships between proteasomes and viral gene products.

Authors:  A S Jarrousse; K Gautier; S Apcher; S Badaoui; G Boissonnet; M H Dadet; L Henry; J P Bureau; H P Schmid; F Petit
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

2.  Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.

Authors:  Y Gao; S Lecker; M J Post; A J Hietaranta; J Li; R Volk; M Li; K Sato; A K Saluja; M L Steer; A L Goldberg; M Simons
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 3.  The ubiquitin/26S proteasome system in plant-pathogen interactions: a never-ending hide-and-seek game.

Authors:  Anne-Sophie Dielen; Saloua Badaoui; Thierry Candresse; Sylvie German-Retana
Journal:  Mol Plant Pathol       Date:  2010-03       Impact factor: 5.663

4.  Polyubiquitin substrates allosterically activate their own degradation by the 26S proteasome.

Authors:  Dawadschargal Bech-Otschir; Annett Helfrich; Cordula Enenkel; Gesa Consiglieri; Michael Seeger; Hermann-Georg Holzhütter; Burkhardt Dahlmann; Peter-Michael Kloetzel
Journal:  Nat Struct Mol Biol       Date:  2009-01-25       Impact factor: 15.369

5.  HIV-1 Tat regulates cyclin B1 by promoting both expression and degradation.

Authors:  Shi-Meng Zhang; Yi Sun; Rong Fan; Qin-Zhi Xu; Xiao-Dan Liu; Xiangming Zhang; Ya Wang; Ping-Kun Zhou
Journal:  FASEB J       Date:  2009-10-13       Impact factor: 5.191

6.  HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures.

Authors:  M Y Aksenov; M V Aksenova; C F Mactutus; R M Booze
Journal:  Neurosci Lett       Date:  2010-04-02       Impact factor: 3.046

Review 7.  Harnessing proteasome dynamics and allostery in drug design.

Authors:  Maria Gaczynska; Pawel A Osmulski
Journal:  Antioxid Redox Signal       Date:  2014-02-21       Impact factor: 8.401

8.  MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape.

Authors:  Phillip Pymm; Patricia T Illing; Sri H Ramarathinam; Geraldine M O'Connor; Victoria A Hughes; Corinne Hitchen; David A Price; Bosco K Ho; Daniel W McVicar; Andrew G Brooks; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian
Journal:  Nat Struct Mol Biol       Date:  2017-02-20       Impact factor: 15.369

Review 9.  Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine.

Authors:  Wesley N Wayman; Lihua Chen; Amanda L Persons; T Celeste Napier
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

10.  Interactions of SARS coronavirus nucleocapsid protein with the host cell proteasome subunit p42.

Authors:  Qin Wang; Chuan Li; Quanfu Zhang; Tao Wang; Jiandong Li; Wuxiang Guan; Jianshi Yu; Mifang Liang; Dexin Li
Journal:  Virol J       Date:  2010-05-17       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.